Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06462170
NA

Pancreatic Insulin Production Capacity (PIPC) - a Feasibility Study

Sponsor: Ottawa Hospital Research Institute

View on ClinicalTrials.gov

Summary

The standard treatment for Type 2 diabetes involves management of the disease based on average of blood glucose control over the past few months. In this study, the investigators test for the participants' ability to produce insulin, which is the hormone that the body makes to control blood sugar levels. The body produces insulin in response to eating. The participants will drink a meal replacement shake, and then test the blood for levels of insulin produced over 2 hours. With blood tests taken five times over two hours, the investigators will measure the blood glucose (sugar), and insulin levels. This study will assess the differences in insulin produced in the participants and try to understand the reasons for these differences.

Official title: The Feasibility of an Innovative Protocol to Demonstrate the Impact of Positive Energy Balance on Pancreatic Insulin Production Capacity (PIPC)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2024-06-24

Completion Date

2025-09-30

Last Updated

2024-06-26

Healthy Volunteers

No

Conditions

Interventions

DIETARY_SUPPLEMENT

Boost Original meal replacement shake

One bottle of Boost Original meal replacement shake.

Locations (1)

The Ottawa Hospital

Ottawa, Ontario, Canada